| Medical therapy for obesity--current status and future hopes. | |
| | |
MedLine Citation:
|
PMID: 17964918 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In accepting any new drug for the treatment of obesity, the safety profile must make it acceptable for almost everyone. Criteria for selecting treatments involve evaluating the risks to the individual from obesity and balancing that against any possible problems with the treatment. Obesity is a chronic disease that has many causes. Cure is rare and treatment is thus aimed at palliation, that is, producing and maintaining weight loss. Wherever the primary site of action may be, however, the net effect must be a reduction in food intake or an increase in energy expenditure. |
| | |
Authors:
|
George A Bray |
Related Documents
:
|
2086518 - Obesity--a state of reduced sympathetic activity and normal or high adrenal activity (t... 1548858 - Is childhood obesity associated with high-fat foods and low physical activity? 20363238 - Effect of serum estradiol and leptin levels on thyroid function, food intake and body w... 17428898 - Intermittent intraperitoneal infusion of peptide yy(3-36) reduces daily food intake and... 11850698 - Effect of food on the pharmacokinetics and pharmacodynamics of torsemide. 2086518 - Obesity--a state of reduced sympathetic activity and normal or high adrenal activity (t... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: The Medical clinics of North America Volume: 91 ISSN: 0025-7125 ISO Abbreviation: Med. Clin. North Am. Publication Date: 2007 Nov |
Date Detail:
|
Created Date: 2007-10-29 Completed Date: 2007-12-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 2985236R Medline TA: Med Clin North Am Country: United States |
Other Details:
|
Languages: eng Pagination: 1225-53, xi Citation Subset: AIM; IM |
Affiliation:
|
Pennington Center, 6400 Perkins Road, Baton Rouge, LA 70808, USA. brayga@pbrc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-Obesity Agents
/
therapeutic use* Clinical Trials as Topic Humans Obesity / drug therapy* Sympathomimetics / therapeutic use* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Obesity Agents; 0/Sympathomimetics |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
Next Document: Bariatric surgery for morbid obesity--a cure for metabolic syndrome?